Glympse Bio Company
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Investors
Industry:
Clinical Development, Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
17
Total Funding:
93299987
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-17
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership